KALA BIO, Inc. (KALA)
NASDAQ: KALA · Real-Time Price · USD
6.64
-0.20 (-2.92%)
Feb 21, 2025, 4:00 PM EST - Market closed
KALA BIO Employees
KALA BIO had 43 employees as of December 31, 2023. The number of employees increased by 9 or 26.47% compared to the previous year.
Employees
43
Change (1Y)
9
Growth (1Y)
26.47%
Revenue / Employee
n/a
Profits / Employee
-$906,116
Market Cap
40.45M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 72,000 |
KALA News
- 10 days ago - KALA BIO Announces Chief Executive Officer Transition - GlobeNewsWire
- 7 weeks ago - KALA BIO Announces $10,750,000 Private Placement - GlobeNewsWire
- 3 months ago - KALA BIO to Present at Piper Sandler 36th Annual Healthcare Conference - GlobeNewsWire
- 9 months ago - KALA BIO to Present at Jefferies Global Healthcare Conference - GlobeNewsWire
- 10 months ago - KALA BIO Reports First Quarter 2024 Financial Results and Provides Corporate Update - GlobeNewsWire
- 11 months ago - KALA BIO Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update - GlobeNewsWire
- 1 year ago - KALA BIO to Present at TD Cowen 44th Annual Healthcare Conference - GlobeNewsWire
- 1 year ago - KALA BIO Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire